REGISTERED
on 29 Oct 2024
Last Applicant/ Owned by
PO Box 352
Middletown
NY
10940
Serial Number
98238543 filed on 24th Oct 2023
Registration Number
7548933 registered on 29th Oct 2024
Correspondent Address
Middletown, NY 10940
United States
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
SUCCESSFUL HUMAN FACTORS
Business management consulting, strategic planning and business advisory services provided to organizations needing services related to usability testing, UX research, human factors, strategy, planning and execution of the same, unique with a strong focus on project management, operational excellence, optimization in the field of human factors engineering projects.
Classification Information
Class [035]
Advertising, Business & Retail Services
Business management consulting, strategic planning and business advisory services provided to organizations needing services related to usability testing, UX research, human factors, strategy, planning and execution of the same, unique with a strong focus on project management, operational excellence, optimization in the field of human factors engineering projects.
First Use Date in General
12th Jun 2020
First Use Date in Commerce
22nd Dec 2020
Mark Details
Serial Number
No 98238543
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 29th Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th Aug 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Aug 2024 | PUBLISHED FOR OPPOSITION |
| 24th Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 02th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 02th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 02th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 14th May 2024 | NON-FINAL ACTION WRITTEN |